Category Archives: Events
Oakwood Labs will be exhibiting at Booth #31 and speaking at the upcoming 2024 PODD Conference taking place from October 28-29 in Boston. If you would like to learn more about the event and register to attend, please visit the following link: https://poddconference.com/
Company Overview
Oakwood Labs is a global leader in sustained release drug delivery. We support all phases of long acting injectable development from initial feasibility studies through FDA-approved clinical and commercial supply. Oakwood has 27 years of drug encapsulation experience using Chroniject™, our patented microsphere-based technology. Chroniject™ provides the ability to control particle size, customize release durations from weeks to years, and minimize residual solvents to achieve critical quality attributes.
Listen to Oakwood’s presentation during Day 1 on our Chroniject Technology: A Solution to Long Acting Injectable Formulation and Scale-Up Challenges
Colin Spencer, a project manager working within our technology transfer team will be presenting during Day 1 (Monday, October 28th) of the conference within the Track 1A: Injectable Formulations & Technologies at 2:30pm.
The presentation will include the following key points:
- Oakwood’s Chroniject technology provides a tunable long-acting injectable platform for a wide array of molecules and applications. Efficacious release profiles have been generated from as fast as two days to as long as one year.
- Oakwood’s Chroniject technology provides the platform for scale-up of the formulation process, allowing for the critical quality attributes of the long-acting injectable formulations to be maintained from initial feasibility batch sizes in the gram-scale to clinical and commercial batch sizes in the kilogram-scale.
Stop by Oakwood Lab’s Booth #31 to meet our team and learn more about how we can assist in the following areas:
- Long Acting Injectable Patented Technology (CDMO Services)
- Feasibility assessments
- Scale-up and optimization of lead formulation
- Manufacturing, characterization, and stability of R&D toxicology batches
- GMP Clinical trial manufacturing (Phase I, II, III)
- GMP Commercial manufacturing
- Contract Manufacturing (CMO Services)
- Technology Transfer
- GMP Registration and Validation batches
- Aseptic GMP commercial batch manufacturing
- ICH compliant stability testing
Contact Us for More Information
PODD 2024 conference covers a wide range of topics, and we are happy to contribute to the event! If you aren’t able to attend, but still want to learn more about Oakwood Labs or what you missed at the conference, contact us today!
We look forward to discussing our technology and more.
Oakwood Labs is happy to announce that we will be exhibiting at Booth #2610 at the upcoming 2024 AAPS PharmSci 360 on October 20-23 in Salt Lake City, Utah. If you would like to learn more about the event and register to attend, please visit the following link: https://www.aaps.org/pharmsci/annual-meeting
Company Overview
Oakwood Labs is a global leader in sustained release drug delivery. We support all phases of long acting injectable development from initial feasibility studies through FDA-approved clinical and commercial supply. Oakwood has 27 years of drug encapsulation experience using Chroniject™, our patented microsphere-based technology. Chroniject™ provides the ability to control particle size, customize release durations from weeks to years, and minimize residual solvents to achieve critical quality attributes.
Stop by Oakwood Lab’s Booth #2610 to meet our team and learn more about how we can assist in the following areas:
- Long Acting Injectable Technology (CDMO)
- Feasibility studies
- Scale-up of formulation
- Manufacturing toxicology batches
- Clinical trial manufacturing (Phase I, II, III)
- Contract Manufacturing (CMO)
- Technology Transfer
- GMP Registration and Validation batches
- Aseptic GMP commercial batch manufacturing
- ICH compliant stability testing
Contact Us for More Information
The AAPS 2024 conference covers a wide range of topics, and we are happy to contribute to the event! If you aren’t able to attend, but still want to learn more about Oakwood Labs or what you missed at the conference, contact us today!
We look forward to discussing our technology and more.
Oakwood Labs is happy to announce that we will be at the 2024 Drug Delivery and Formulation Summit on September 17-18 in San Diego. If you would like to learn more about the event and register to attend, please visit the following link: https://ddfsummit.com/DDF2024/en/page/home
Company Overview
Oakwood Labs is a global leader in sustained release drug delivery. We support all phases of long acting injectable development from initial feasibility studies through FDA-approved clinical and commercial supply. Oakwood has 25 years of drug encapsulation experience using Chroniject™, our patented microsphere-based technology. Chroniject™ provides the ability to control particle size, customize release durations from weeks to years, and minimize residual solvents to achieve critical quality attributes.
Stop by Oakwood Lab’s Booth #20 to meet our team and learn more about how we can assist in the following areas:
- Long Acting Injectable Technology
- Feasibility studies
- Scale-up of formulation
- Manufacturing toxicology batches
- Clinical trial manufacturing (Phase I, II, III)
- Contract Manufacturing
- Technology Transfer
- GMP Registration and Validation batches
- Aseptic GMP commercial batch manufacturing
- ICH compliant stability testing
Contact Us for More Information
The DDF 2024 conference covers a wide range of topics, and we are happy to contribute to the event! If you aren’t able to attend, but still want to learn more about Oakwood Labs or what you missed at the conference, contact us today!
We look forward to discussing our technology and more.
Oakwood Labs is proud to announce that we will be at the 2023 Controlled Release Society 2023 annual meeting and expo, July 24-28, 2023. The theme this year is “The Future of Delivery Science,” which focuses on the next generation of scientists and progressive research that is being conducted around the world.
Find Us at Booth 304
As a global leader in sustained-release drug delivery, Oakwood Labs is able to solve changes related to developing and manufacturing pharmaceutical injectables. We pride ourselves on being transparent with our clients throughout the whole process and offering our expertise. If you’re looking for state-of-the-art technology, personnel, and equipment, you’ll want to check out Oakwood Labs at booth #304.
We can help you with the following:
- Clinical trial manufacturing (Phase I, II, III)
- Feasibility studies
- Pre-formulation development activities
- Commercial aseptic GMB manufacturing
- Scale-up of formulation
- Manufacturing toxicology batches
- ICH compliant stability testing
Contact Us for More Information
The CRS 2023 conference covers a wide range of topics, and we are happy to contribute to the event! If you aren’t able to attend, but still want to learn more about Oakwood Labs or what you missed at the conference, contact us today!
We look forward to discussing our technology and more.
This year’s PDA Annual Meeting is occurring April 4-6 in Dallas, TX. This event is focused on the theme of “Level Up: Agility in the New Normal” and will highlight items to look forward to in the future of pharmaceutical manufacturing.
Incorporating speakers, networking events, and panel discussions, this is an event that you will not want to miss. This year, we are excited to announce that we will be featured as an exhibitor.
We Look Forward to Seeing You
Our team has been focused on researching and developing sustained-release injectables, and we are always looking for opportunities to chat about our discoveries and processes. If you are looking for an aseptic lab staffed by experts, consider Oakwood Labs for your next project, as we can assist you in the following:
- Pre-formulation development activities
- Feasibility studies
- Scale-up of formulation
- Manufacturing toxicology batches
- ICH compliant stability testing
- Clinical trial manufacturing (Phase I, II, III)
- Commercial aseptic GMP manufacturing
We are so excited to meet you and show you what we have been working on, so be sure to come to visit the Oakwood Labs team at Booth #308.
Don’t Hesitate to Reach Out
The 2022 PDA Annual Meeting is sure to inform us about new trends and inspire us to be innovative as we take on the pharmaceutical challenges that lie ahead. If you are unable to attend the event, we would be happy to chat about our experience at the occasion or provide information on extended-release technology and more.
Reach out today with any questions you may have. We look forward to seeing you soon!
Join Oakwood Labs for a complimentary webinar on August 24th, 2021 at 11 a.m. EST. This webinar will discuss a corporate overview and Oakwood’s approach to development of extended-release and long-acting injectables.
Oakwood’s capabilities include the following:
- Pre-formulation development activities
- Feasibility studies
- Scale-up of formulation
- Manufacturing toxicology batches
- ICH compliant stability testing
- Clinical trial manufacturing (Phase I, II, III)
- Commercial aseptic GMP manufacturing
Reach Out to Oakwood Labs Today About Extended-Release Injectables
Contact us today to learn more about the extended-release solutions we can provide for your company. We look forward to hearing from you.